Technescan MAG3 TECHNESCAN TC 99M MERTIATIDE CURIUM US LLC FDA Approved Technescan MAG3™ is a kit for the preparation of technetium Tc 99m mertiatide, a diagnostic radiopharmaceutical. It is supplied as a sterile, nonpyrogenic, lyophilized powder. Each vial contains betiatide (N-[N-[N-[(benzoylthio) acetyl]glycyl]glycyl]-glycine). After reconstitution with sterile sodium pertechnetate Tc 99m injection, the technetium Tc 99m mertiatide (disodium[N-[N-[N-(mercaptoacetyl) glycyl]glycyl] glycinato (2-) - N,N′,N″,S′]oxotechnetate (2-)) which is formed is suitable for intravenous administration. Each 10 milliliter vial contains 1 milligram betiatide, 0.05 milligram (minimum) stannous chloride dihydrate (SnCl 2 •2H 2 O) and 0.2 milligram (maximum) total tin expressed as stannous chloride dihydrate (SnCl 2 •2H 2 O), 40 milligrams sodium tartrate dihydrate (Na 2 C 4 H 2 O 6 •2H 2 O), and 20 milligrams lactose monohydrate. Prior to lyophilization, sodium hydroxide or hydrochloric acid may be added for pH adjustment. The pH of the reconstituted drug is between 5.0 and 6.0. No bacteriostatic preservative is present. The contents are sealed under argon. Betiatide is light sensitive and must be protected from light. Betiatide and technetium Tc 99m mertiatide have the following structural formulas: image description image description
FunFoxMeds bottle
Substance Betiatide
Route
INTRAVENOUS
Applications
NDA019882
Package NDC

Drug Facts

Composition & Profile

Strengths
1 mg 0.05 mg 0.2 mg 40 mg 20 mg
Treats Conditions
Indications And Usage Technetium Tc 99m Mertiatide Is A Renal Imaging Agent For Use In The Diagnosis Of Congenital And Acquired Abnormalities Renal Failure Urinary Tract Obstruction And Calculi In Adults And Pediatric Patients See Pediatric Use It Is A Diagnostic Aid In Providing Renal Function Split Function Renal Angiograms And Renogram Curves For Whole Kidney And Renal Cortex

Identifiers & Packaging

Container Type BOTTLE
All Product Codes
UNII
9NV2SR34P8
Packaging

HOW SUPPLIED Catalog Number 096. Technescan MAG3 is supplied as a lyophilized powder packaged in vials. Each reaction vial contains 1 mg betiatide, 0.05 mg (minimum) stannous chloride dihydrate (SnCl 2 •2H 2 O), 0.2 mg (maximum) total tin expressed as stannous chloride dihydrate (SnCl 2 •2H 2 O), 40 mg sodium tartrate dihydrate (Na 2 C 4 H 2 O 6 •2H 2 O), and 20 mg lactose monohydrate. The pH of the reconstituted drug is between 5.0 and 6.0. No bacteriostatic preservative is present. Packages containing 5 reaction vials (NDC 69945-096-20) are available.; PRINCIPAL PANEL DISPLAY - A096V0 Technescan MAG3 ™ Kit for the Preparation of Technetium Tc 99m Mertiatide Diagnostic Vial contains: 1 mg Betiatide 0.05 mg (minimum) Stannous Chloride Dihydrate (SnCl 2 ● 2H 2 O) 40 mg Sodium Tartrate Dihydrate 0.2 mg (maximum) Total Tin as Stannous Chloride Dihydrate (SnCl 2 ● 2H 2 O) 20 mg Lactose Monohydrate Prior to lyophilization, sodium hydroxide or hydrochloric acid may be added for pH adjustment. The pH of the reconstituted drug is between 5.0 and 6.0. The contents are sealed under argon. Sterile, non-pyrogenic. For intravenous use after drug preparation. See package insert for directions for use. Store at 20˚ to 25˚C (68˚ to77˚F) and protect from light. Do not use sodium pertechnetate Tc 99m solutions containing an oxidizing agent. Rx only Manufactured by: Curium US LLC Maryland Heights, MO 63043 Made in USA CURIUM TM A096V0 R12/2018 image description

Package Descriptions
  • HOW SUPPLIED Catalog Number 096. Technescan MAG3 is supplied as a lyophilized powder packaged in vials. Each reaction vial contains 1 mg betiatide, 0.05 mg (minimum) stannous chloride dihydrate (SnCl 2 •2H 2 O), 0.2 mg (maximum) total tin expressed as stannous chloride dihydrate (SnCl 2 •2H 2 O), 40 mg sodium tartrate dihydrate (Na 2 C 4 H 2 O 6 •2H 2 O), and 20 mg lactose monohydrate. The pH of the reconstituted drug is between 5.0 and 6.0. No bacteriostatic preservative is present. Packages containing 5 reaction vials (NDC 69945-096-20) are available.
  • PRINCIPAL PANEL DISPLAY - A096V0 Technescan MAG3 ™ Kit for the Preparation of Technetium Tc 99m Mertiatide Diagnostic Vial contains: 1 mg Betiatide 0.05 mg (minimum) Stannous Chloride Dihydrate (SnCl 2 ● 2H 2 O) 40 mg Sodium Tartrate Dihydrate 0.2 mg (maximum) Total Tin as Stannous Chloride Dihydrate (SnCl 2 ● 2H 2 O) 20 mg Lactose Monohydrate Prior to lyophilization, sodium hydroxide or hydrochloric acid may be added for pH adjustment. The pH of the reconstituted drug is between 5.0 and 6.0. The contents are sealed under argon. Sterile, non-pyrogenic. For intravenous use after drug preparation. See package insert for directions for use. Store at 20˚ to 25˚C (68˚ to77˚F) and protect from light. Do not use sodium pertechnetate Tc 99m solutions containing an oxidizing agent. Rx only Manufactured by: Curium US LLC Maryland Heights, MO 63043 Made in USA CURIUM TM A096V0 R12/2018 image description

Overview

Technescan MAG3™ is a kit for the preparation of technetium Tc 99m mertiatide, a diagnostic radiopharmaceutical. It is supplied as a sterile, nonpyrogenic, lyophilized powder. Each vial contains betiatide (N-[N-[N-[(benzoylthio) acetyl]glycyl]glycyl]-glycine). After reconstitution with sterile sodium pertechnetate Tc 99m injection, the technetium Tc 99m mertiatide (disodium[N-[N-[N-(mercaptoacetyl) glycyl]glycyl] glycinato (2-) - N,N′,N″,S′]oxotechnetate (2-)) which is formed is suitable for intravenous administration. Each 10 milliliter vial contains 1 milligram betiatide, 0.05 milligram (minimum) stannous chloride dihydrate (SnCl 2 •2H 2 O) and 0.2 milligram (maximum) total tin expressed as stannous chloride dihydrate (SnCl 2 •2H 2 O), 40 milligrams sodium tartrate dihydrate (Na 2 C 4 H 2 O 6 •2H 2 O), and 20 milligrams lactose monohydrate. Prior to lyophilization, sodium hydroxide or hydrochloric acid may be added for pH adjustment. The pH of the reconstituted drug is between 5.0 and 6.0. No bacteriostatic preservative is present. The contents are sealed under argon. Betiatide is light sensitive and must be protected from light. Betiatide and technetium Tc 99m mertiatide have the following structural formulas: image description image description

Indications & Usage

Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use. ) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.

Dosage & Administration

The suggested dose range employed in the average adult patient (70 kg) for renal function and imaging studies is 185 MBq (5 mCi) to 370 MBq (10 mCi). In pediatric patients the recommended dose range is 2.6 MBq/kg (70 μCi/kg) to 5.2 MBq/kg (140 μCi/kg) with a minimum dose of 37 MBq (1 mCi). The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Aseptic procedures and a shielded syringe should be employed in withdrawing doses for administration to patients. The user should wear waterproof gloves during the administration procedure.

Warnings & Precautions
WARNINGS None known.
Contraindications

None known.

Adverse Reactions

The following adverse reactions have been reported: nausea, vomiting, wheezing, dyspnea, itching, rash, tachycardia, hypertension, shaking chills, fever, and seizure.

Storage & Handling

STORAGE Technescan MAG3 should be stored at controlled room temperature 20° to 25°C (68° to 77°F) and protected from light until use. The reconstituted vial should be stored at room temperature (15° to 30°C) and must be used within six hours of preparation. Table 4. Radiation Dose Estimates for Tc 99m Mertiatide *Calculated by Oak Ridge Associated Universities, based upon the pediatric phantom series of Christy and Eckerman of Oak Ridge National Laboratories. The adult radiation absorbed doses were calculated based on data from ten normal volunteers using the Medical Internal Radiation Dose Committee (MIRD) schema. **Radioactive doses for 1-, 5-, and 10-year olds are based on a maximum dose of 7.4 MBq/kg (200 μCi/kg). 8-day Old 1-year Old** 5-year Old** 10-year Old** 15-year Old Adult Assumed Weight (kg) 3.4 9.8 19 32 57 70 Tc 99m Mertiatide Dose 37 MBq (1 mCi) 72.52 MBq (1.96 mCi) 140.6 MBq (3.8 mCi) 236.8 MBq (6.4 mCi) 370 MBq (10 mCi) 370 MBq (10 mCi) Organ mSv rem mSv rem mSv rem mSv rem mSv rem mSv rem Gallbladder Wall 2.701 0.27 2.466 0.235 1.547 0.160 1.658 0.166 1.961 0.200 1.628 0.160 Lower Large Intestine Wall 1.739 0.17 1.595 0.161 2.250 0.220 2.368 0.237 4.070 0.400 3.256 0.330 Small Intestine 0.518 0.052 0.5439 0.055 1.195 0.122 1.397 0.141 2.035 0.200 1.628 0.160 Upper Large Intestine Wall 0.962 0.096 0.943 0.096 1.828 0.186 2.0365 0.205 2.442 0.250 1.887 0.190 Kidneys 1.406 0.14 1.088 0.112 1.308 0.129 1.5155 0.154 1.739 0.180 1.443 0.140 Liver 0.3219 0.032 0.3046 0.031 0.394 0.038 0.4262 0.0435 0.481 0.048 0.3626 0.036 Ovaries 0.592 0.058 0.6164 0.061 1.322 0.133 1.5392 0.154 3.330 0.330 2.5900 0.260 Red Marrow 0.1628 0.016 0.1595 0.0161 0.281 0.0277 0.3552 0.0352 0.629 0.063 0.4810 0.050 Testes 0.518 0.051 0.5294 0.053 1.0826 0.110 1.1840 0.122 2.368 0.240 1.628 0.160 Urinary Bladder Wall 11.470 1.1 9.428 0.921 21.090 2.090 23.680 2.368 59.20 6.00 48.1000 4.80 Total Body 0.2405 0.024 0.2176 0.022 0.3656 0.0365 0.4026 0.0410 0.814 0.081 0.6660 0.065


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →